-
JAKKS Extends Contract With Black+Decker
2021 Jun 18, 3:55pm | 212Read More...Toy and consumer products manufacturer JAKKS Pacific Inc (NASDAQ: JAKK) announced a multi-year North America contract extension with Stanley Black & Decker, Inc (NYSE: SWK), a power tools manufacturer. The financial terms of the deal were not disclosed. Under...
-
Palantir Technologies Bags One Year $18.4M FAA's Aviation Safety Transformation Contract
2021 Jun 18, 9:01am | 154Read More...Palantir Technologies Inc (NYSE: PLTR) won a one-year $18.4 million Federal Aviation Administration (FAA) contract to provide a data analytics tool to drive the agency's aviation safety modernization objectives. The contract has two additional option years. Palantir Foundry will...
-
Bristol Myers Inks Licensing Pact For Eisai's Folate Receptor ADC Drug, Lays Out Over $3B For Rights
2021 Jun 18, 7:05am | 302Read More...Eisai Co Ltd (OTC: ESALY) and Bristol-Myers Squibb Co (NYSE: BMY) have entered into an exclusive global strategic collaboration agreement for the co-development and co-commercialization of MORAb-202, an antibody-drug conjugate (ADC). Bristol Myers will pay $650 million,...
-
Gan Partners With Incredible Technologies For Online Games Distribution
2021 Jun 17, 3:24pm | 259Read More...Internet gaming software service provider Gan Ltd (NASDAQ: GAN) has signed an agreement with Illinois-based Incredible Technologies Inc (IT), a designer and manufacturer of coin-operated video games and Class III casino games. The financial terms of the deal...
-
Processa Pharmaceuticals In-Licenses Ocuphire's Anticancer Agent
2021 Jun 17, 1:55pm | 236Read More...Processa Pharmaceuticals Inc (NASDAQ: PCSA) has entered into a licensing agreement with Ocuphire Pharma Inc (NASDAQ: OCUP) to in-license RX-3117. RX-3117 is an oral anticancer agent with an improved pharmacological profile relative to gemcitabine and other nucleoside...
-
Gilead's Kite Pharma Collaborates With Shoreline Biosciences For Cell Therapies For Cancer Settings
2021 Jun 17, 1:52pm | 190Read More...Kite Pharma, a unit of Gilead Sciences Inc (NASDAQ: GILD) and Shoreline Biosciences Inc, has entered into a strategic partnership to develop novel cell therapies across various cancer targets. The collaboration will focus initially on chimeric antigen receptor (CAR) NK...
-
Why AMD's Stock Is Trading Higher Today
2021 Jun 17, 10:41am | 165Read More...Advanced Micro Devices, Inc. (NASDAQ: AMD) shares are trading higher after the company, and Google Cloud, announced T2D, the first instance in the new family of Tau Virtual Machines powered by 3rd Gen AMD EPYC processors. "By collaborating with AMD, Google Cloud customers can now leverage...
-
Synlogic, Roche Ink Research Pact For Inflammatory Bowel Disease Therapy
2021 Jun 17, 10:26am | 162Read More...Synlogic Inc (NASDAQ: SYBX) has entered into a research collaboration agreement with Roche Holding AG (OTC: RHHBY) for the discovery of Synthetic Biotic medicine for inflammatory bowel disease (IBD). Under the terms of the agreement, Synlogic and Roche will collaborate to...
-
Lineage Inks Option Agreement With Amasa Therapeutics For HyStem
2021 Jun 17, 9:09am | 194Read More...Lineage Cell Therapeutics Inc (NYSE: LCTX) has granted an exclusive option to Amasa Therapeutics Inc to acquire an exclusive, royalty-bearing license to use its HyStem technology to develop and commercialize therapies for local treatment of solid tumors under pre-negotiated terms....
-
Mantech Bags $61M DoD Warfare Technical Support Contract
2021 Jun 17, 8:38am | 116Read More...Mantech International Corp (NASDAQ: MANT) won a $61 million contract to provide systems engineering and technical assistance (SETA) services to the Department of Defense (DoD) Irregular Warfare Technical Support Directorate (IWTSD). The contract is for one year with four one-year...
-
PhaseBio Stock Jumps On Bentracimab Commercialization Pact In Europe
2021 Jun 17, 8:35am | 203Read More...PhaseBio Pharmaceuticals Inc (NASDAQ: PHAS) has entered into an exclusive licensing agreement with privately-held Alfasigma S.p.A for the commercialization of bentracimab. The agreement covers countries in the European Union and European Economic Area, and the U.K., Russia, Ukraine...
-
FibroGen In-Licenses Three HiFiBiO Programs For Cancer, Autoimmune Settings
2021 Jun 17, 8:29am | 196Read More...FibroGen Inc (NASDAQ: FGEN) and HiFiBiO Therapeutics have entered into a licensing agreement for three programs in the immuno-oncology and autoimmune space. FibroGen exclusively in-licenses HiFiBiO's Galectin-9 program and obtains an exclusive option to their CXCR5 and CCR8...
-
Raw Material Shortage Holding Up Novavax's COVID-19 Shot Manufacturing, Says Serum Institute
2021 Jun 17, 7:15am | 310Read More...Serum Institute of India (SII) is yet to receive raw materials from the U.S. required to produce the Novavax Inc (NASDAQ: NVAX) vaccine despite diplomatic interventions by India, said an official aware of the development. The delay in receiving raw materials such as bioreactor...
-
JNJ Unlikely To Meet Q2 COVID-19 Vaccine Supply Target To EU: Reuters
2021 Jun 16, 12:44pm | 260Read More...Johnson & Johnson (NYSE: JNJ) will miss its COVID-19 vaccine supply target to the European Union for the second quarter after millions of doses were found unfit for use, Reuters reported citing the E.U. Commission spokesman. The EMA last week said JNJ doses sent to Europe from a...
-
Genasys Bags Third US Army LRAD® 450XL Order In FY21
2021 Jun 16, 12:07pm | 227Read More...Genasys Inc (NASDAQ: GNSS) announced a follow-on $9.7 million order from the U.S. Army. It marked the third LRAD® 450XL order in FY21 under the Army's Acoustic Hailing Device (AHD) program of record. The LRAD 450XL offered critical long-range communication and scalable...
